Barclays Maintains Overweight on Morgan Stanley, Raises Price Target to $125

Morgan Stanley (NYSE:MS) had its price objective increased by Barclays from $105.00 to $125.00 in a research note published on Tuesday。Barclays currently has an overweight rating。